Phase II Clinical Study of TR-012001 in Japanese Patients With Parkinson's Disease

NCT06212089 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: TR-012001
OTHER: Placebo

Sponsor

SNLD, Ltd.